arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ACADIA PHARMACEUTICALS INC

ACAD

$29.23 ▲ +0.78 (+2.72%) at close

18 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

ACADIA PHARMACEUTICALS INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $4.9B

Dividend Yield —

Revenue Growth 11.9% ↘

Op. Margin 9.8% ↘

ROIC 24.0% ↘

FCF / Share $0.62 ↘

Trailing P/E 12.6x

Price / Book 4.1x

FCF Yield 2.1%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.07B

↑ +11.9% —

Net Income Profit after all expenses

$391.00M

↑ +72.7% —

Operating Margin Operating profit as % of sales

9.8%

↓ -59.4% 56th

FCF / Share Free cash flow per share

$0.62

↓ -34.2% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	11.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+48%)	31.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+298%)	40.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+406%)	6.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-15%)	9.6% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20%)	30.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+279%)	51.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+544%)	79.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+890%)	620.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7658%)	28311.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+353793%)	-49.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-715%)	-89.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1219%)	-76.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1058%)	137.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1617%)	-95.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1289%)	558.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6881%)	—	—
EPS Growth YoY (%)	69.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	72.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-27.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	13.6% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—
Net Income Growth YoY (%)	72.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	71.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-28.7% Weak ↓ Weak Declining Year-over-year change in net income	40.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-19.7% Weak ↓ Weak Declining Year-over-year change in net income	4.1% Caution ↑ Caution Improving Year-over-year change in net income	15.3% Good ↑ Good Improving Year-over-year change in net income	-6.6% Weak ↑ Weak Improving Year-over-year change in net income	-65.0% Weak ↑ Weak Improving Year-over-year change in net income	-77.8% Weak ↓ Weak Declining Year-over-year change in net income	-143.7% Weak ↓ Weak Declining Year-over-year change in net income	-82.0% Weak Weak Year-over-year change in net income	8.4% Fair Fair Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%)	-34.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	833.2% Excellent Excellent Year-over-year change in free cash flow	N/M	10.7% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	-2.9% Weak ↑ Weak Improving Year-over-year change in free cash flow	-37.5% Weak Weak Year-over-year change in free cash flow	24.3% Good Good Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	27.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	25.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	18.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	15.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	29.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	52.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	169.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	1442.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	913.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	147.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-76.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-61.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-69.9% Weak Weak Compound annual revenue growth over 3 years	-8.5% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	19.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	23.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	26.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	32.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	94.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	491.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	390.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	187.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	91.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	53.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-73.0% Weak Weak Compound annual revenue growth over 5 years	-54.9% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	9.8% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-35%)	24.1% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+61%)	-10.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	-43.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-388%)	-35.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-335%)	-64.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-532%)	-72.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-585%)	-110.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-837%)	-234.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1661%)	—	—	—	—	-425.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2938%)	—	35.8% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+139%)	—	—
Effective Tax Rate (%) (%)	-181.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-20.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	36.5% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+204%)	23.6% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+97%)	-8.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-170%)	-41.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-448%)	-34.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-389%)	-63.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-631%)	-69.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-678%)	-109.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1013%)	-231.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2031%)	—	—	—	—	-424.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3641%)	—	35.9% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+199%)	—	—
FCF Margin (%) (%)	9.8% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	16.4% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	2.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-22.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-26.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-32.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-44.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-75.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-175.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	-440.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-25.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-214.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.71x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	24.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	27.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-56.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-51.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-87.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-77.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	40.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-296.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	6.7% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	19.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-76.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-48.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-74.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	39.3% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	31.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+112%)	30.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+106%)	-14.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-53.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-460%)	-31.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-307%)	-44.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-399%)	-33.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-324%)	-51.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-441%)	-86.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-675%)	-52.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-449%)	-82.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-649%)	-29.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-20.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-97.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-750%)	51.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+240%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Net Debt (USD)	$-177.69M	$-319.59M	$-188.66M	$-114.85M	$-147.44M	$-326.03M	$-189.68M	$-134.76M	$-69.42M	$-163.62M	$-102.14M	$-61.85M	$-11.71M	$-57.90M	$-6.89M	$-6.85M	$-18.12M	$-21.17M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$6.36	$5.78	$4.43	$3.20K	$3.02K	—	—	—	—	—	—	—	—	$0.09	$0.04	$1.09	$0.17	—
Basic EPS, GAAP (USD)	$2.32	$1.37	$-0.37	$-1.34	$-1.05	—	—	—	—	—	—	—	—	$-0.38	$-0.44	$0.39	$-1.20	—
Free Cash Flow per Share (USD)	$0.62	$0.95	$0.10	$-705.30	$-789.95	—	—	—	—	—	—	—	—	$-0.39	$-0.38	$-0.28	$-0.37	—
Book Value per Share (USD)	$7.21	$4.40	$2.62	$2.47	$3.36	$3.93	$4.50	$3.33	$2.69	$4.27	$1.96	$3.09	$2.00	$1.16	$0.44	$0.75	$0.32	—
Tangible Book Value per Share (USD)	$7.21	$4.40	$2.62	$2.47	$3.36	$3.92	$4.49	$3.30	$2.65	$4.21	$1.96	$3.09	$2.00	$1.16	$0.44	$0.75	$0.32	—
Basic Weighted Avg Shares (shares)	168.36M	165.72M	163.82M	161,683	160,493	—	—	—	—	—	—	—	—	55.12M	52.18M	38.59M	37.48M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$785.00M	$543.45M	$361.87M	$382.31M	$521.75M	$611.65M	$685.42M	$466.54M	$324.45M	$505.31M	$197.09M	$308.78M	$181.38M	$102.60M	$25.78M	$31.89M	—	—
Total Equity (USD)	$1.23B	$732.79M	$431.75M	$400.41M	$540.89M	$627.01M	$699.13M	$479.08M	$335.29M	$518.41M	$199.76M	$309.49M	$182.13M	$84.98M	$23.36M	$29.69M	$12.11M	$52.99M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$1.07B	$957.80M	$726.44M	$517.24M	$484.14M	$441.75M	$339.08M	$223.81M	$124.90M	$17.33M	$61.00K	$120.00K	$1.15M	$4.91M	$2.07M	$42.13M	$6.40M	—
Depreciation Expense (USD)	$871.00K	$920.00K	$1.46M	$2.03M	$2.24M	$1.46M	$1.29M	$1.53M	$1.24M	$843.00K	$647.00K	$206.00K	—	$109.00K	$285.00K	$607.00K	$1.11M	—
Net Income, GAAP (USD)	$391.00M	$226.45M	$-61.29M	$-215.97M	$-167.87M	$-281.58M	$-235.26M	$-245.19M	$-289.40M	$-271.39M	$-164.44M	$-92.47M	$-37.95M	$-20.85M	$-22.77M	$15.14M	$-45.15M	—
Operating Cash Flow (USD)	$109.84M	$157.72M	$16.70M	$-114.03M	$-125.66M	$-136.17M	$-151.13M	$-167.47M	$-217.76M	—	—	—	—	$-21.63M	$-19.90M	$-10.70M	$-13.73M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

ACADIA PHARMACEUTICALS INC

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACAD with peers